The Dmp1 gene, which helps activate p53 and Arf tumor suppressors, malfunctioned in about 35% of 51 human non-small-cell lung cancer samples, experts found. Researchers said the study could help identify the response of patients to chemotherapy and could lead to the development of new cancer drugs.

Related Summaries